Position
Chief Strategy Officer
Company
Ratio Therapeutics
BostonBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Ratio Therapeutics Inc. has appointed Dr. Marcel Reichen as the Chief Strategy Officer, bringing extensive experience in the pharmaceutical industry
Quick answer
Ratio Therapeutics Appoints Marcel Reichen as Chief Strategy Officer (November 4, 2025). Ratio Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Strategy Officer at Ratio Therapeutics?
- Ratio Therapeutics named Marcel Reichen Chief Strategy Officer, announced November 4, 2025.
- What did Ratio Therapeutics announce on November 4, 2025?
- Ratio Therapeutics Inc. has appointed Dr. Marcel Reichen as the Chief Strategy Officer, bringing extensive experience in the pharmaceutical industry
- What does Ratio Therapeutics do?
- Ratio Therapeutics Inc. is a clinical-stage pharmaceutical company with the mission to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment...
- Where is Ratio Therapeutics based?
- Ratio Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Esperion Therapeutics (November 4, 2025), Kalaris Therapeutics (November 3, 2025), Kenox Pharmaceuticals (October 21, 2025) and Nasus Pharma (November 20, 2025) also announced leadership changes within 45 days of Ratio Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Esperion Appoints John Harlow as Chief Commercial Officer (November 4, 2025)
- Kalaris Therapeutics Appoints Matthew Gall as Chief Financial Officer (November 3, 2025)
- Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing (October 21, 2025)
- Nasus Pharma Appoints Eyal Rubin as Chief Financial Officer (November 20, 2025)
- Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer (October 14, 2025)
- Vistagen Appoints Nick Tressler as Chief Financial Officer (December 1, 2025)
Who to call at Ratio Therapeutics, and when
A new leader at Ratio Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ratio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ratio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ratio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ratio Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ratio Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.